Jennifer Plichta, MD, MS, is helping patients navigate a rapidly evolving landscape of risk assessment, screening, prevention, and treatment while advancing research to better understand metastatic breast cancer.
https://medschool.duke.edu/news/jennifer-plichtas-war-breast-cancer

Cardiac sarcoidosis can be difficult to diagnose. A Duke-led clinical trial is testing whether an FDA-approved imaging agent can help identify granulomas in heart tissue and improve detection.
#MedSky
https://medschool.duke.edu/news/duke-collaboration-moves-sarcoidosis-discovery-lab-patients

Neeraj Surana, MD, PhD, and Duke colleagues identified a new link between the gut microbiome and metabolism.

Their research suggests a naturally occurring gut bacterium may help regulate energy expenditure and visceral fat.
https://medschool.duke.edu/news/sweet-discovery-fight-obesity

A decade of research at Duke has led to a first-in-human clinical trial of a new immunotherapy for glioblastoma.
#AcademicSky #MedSky
https://medschool.duke.edu/news/duke-developed-immunotherapy-brain-tumors-heads-clinical-trial?utm_campaign=SoMnews&utm_medium=social&utm_source=bluesky

New research led by Noelle Younge, MD, MHS, finds evidence that the gut microbiome plays a direct role in growth faltering among extremely preterm infants, opening the door to potential new therapies.
https://medschool.duke.edu/news/study-links-gut-bacteria-poor-growth-preterm-infants

From CATHGEN to OneDukeGen, Svati H. Shah, MD, has spent her career advancing cardiovascular genomics and bringing research discoveries closer to patient care.
https://medschool.duke.edu/stories/next-frontier-heart-care?utm_campaign=SoMmagnify&utm_medium=social&utm_source=bluesky

Research from Seok-Yong Lee, PhD, and colleagues at Duke University School of Medicine reveals how cold signals are transmitted to the brain, with findings that could inform therapies for migraine, dry eye, and other conditions.

#AcademicSky #MedSky
https://medschool.duke.edu/news/door-cold